This article delves into the groundbreaking collaboration between Advanced Clinical, a leading clinical research services organization, and StuffThatWorks, a community-based data platform.
The alliance, a novelty in the biopharmaceutical sector, is set to revolutionize clinical research by bringing it closer to patients and caregivers.
This partnership enables Advanced Clinical to tap into StuffThatWorks’ extensive pool of three million global members to streamline clinical trial processes.
The article further explores the key features of the StuffThatWorks for Life Science product, the benefits and opportunities of this collaboration, and how it engages patients directly in research.
By integrating machine learning and crowdsourcing, StuffThatWorks provides a new pathway for discovering effective treatments for chronic conditions.
The implications of this collaboration for the clinical research landscape are examined in detail.
- The collaboration between Advanced Clinical and StuffThatWorks aims to bring clinical research closer to patients and caregivers, which is an industry-first in the biopharmaceutical sector.
- StuffThatWorks has a platform with 3 million members worldwide who share their medical history and update condition and treatment parameters, providing a wealth of structured data on 750 conditions.
- The collaboration enables Advanced Clinical to access diverse patient populations through the geo-located patients on the StuffThatWorks platform, allowing for direct communication, surveys, and focus group activities.
- Advanced Clinical and their clients benefit from lower and faster turnaround, a significantly lower performance-based cost structure, real-time reporting, direct access to patients for input on protocol design and feasibility, and the ability to promote clinical trial opportunities directly to patients.
Partnership Announcement Details
The recent collaboration between Advanced Clinical, a privately held clinical research services organization, and StuffThatWorks, a data-driven community platform, marks an industry-first in the biopharmaceutical sector with the aim of bringing clinical research closer to patients and caregivers.
This data-driven collaboration seeks to revolutionize patient recruitment in clinical trials by leveraging StuffThatWorks’ platform, which boasts 3M members worldwide who share their medical history and treatment parameters, providing a rich and diverse patient database.
This partnership enables Advanced Clinical to directly access and interact with patients in real-time, thereby facilitating a more efficient and inclusive patient recruitment process.
The benefits of this collaboration extend to sponsors who can gain insights into disease journeys through patient community boards.
Platform Capabilities and Features
StuffThatWorks platform offers a range of capabilities and features that enhance its functionality and usability for both researchers and patients.
With its 3M members worldwide, the platform provides comprehensive coverage of 750 conditions and includes structured data points such as demographics, clinical indicators, symptoms, treatments, and wearables data. Genomic data support is also being added, further expanding the platform’s capabilities.
One of the key benefits of the platform is its ability to enhance research accessibility. By providing Advanced Clinical with access to diverse patient populations, the platform plays a crucial role in enabling researchers to gather valuable insights and data.
Additionally, the platform’s unique features allow project teams to directly communicate with patients, conduct surveys, and gain insights into disease journeys through patient community boards.
Furthermore, the platform contributes to improving patient centricity. It empowers patients to share their medical history, condition updates, and treatment parameters, promoting a more collaborative and patient-centered approach to healthcare.
The addition of a user-friendly dashboard also streamlines research processes by allowing researchers to apply trial inclusion and exclusion criteria more efficiently.
In summary, StuffThatWorks platform’s capabilities and features make it a valuable tool for both researchers and patients.
Its comprehensive coverage, data points, and unique functionalities enhance research accessibility, enable direct communication with patients, and promote patient centricity. The user-friendly dashboard further facilitates streamlined research processes.
Benefits and Opportunities
Through this strategic alliance, there are numerous advantages and opportunities for both patients and caregivers, including lower and faster turnaround, real-time reporting, and direct access to patients for input on protocol design and feasibility.
The collaboration promotes a patient-centered research approach, which has the potential to improve trial recruitment and retention significantly.
|Lower and faster turnaround||Improved trial recruitment|
|Real-time reporting||Enhanced retention|
|Direct access to patients||Better protocol design|
|Patient-centered approach||Increased feasibility|
This strategic collaboration between Advanced Clinical and StuffThatWorks is not only transforming how clinical research is conducted but also offering tangible benefits and opportunities for patients, caregivers, and the broader biopharmaceutical community.
Engaging Patients in Research
Engaging select consented patients in the research process can expedite timelines, enhance the quality of data, and provide invaluable insights into specific disease communities.
This collaboration between Advanced Clinical and StuffThatWorks is a prime example of patient empowerment in clinical research. The platform enables direct communication with patients, facilitating a deeper understanding of their experiences.
The significance of this approach lies in the transformation of patient experiences into quantifiable data, thereby contributing effectively to research on specific disease communities.
The data-driven approach not only enhances engagement but also improves the accessibility of clinical trials, thereby revolutionizing the process of clinical research.
The collaboration underscores the importance of patient-centricity and the role of patient experiences in shaping clinical research outcomes.